Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas
Cokgor, Ilkcan, Akabani, Gamal, Kuan, Chien-Tsun, Friedman, Henry S., Friedman, Allan H., Coleman, R. Edward, McLendon, Roger E., Bigner, Sandra H., Zhao, Xiao-Guang, Garcia-Turner, Ana M., Pegram, ChVolume:
18
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2000.18.22.3862
Date:
November, 2000
File:
PDF, 353 KB
2000